Allergy and Immunology, Allergy · West Nyack, NY
NPI
1922064435
Since 2006
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2 Crosfield Ave Ste 406
West Nyack, NY, 10994
Phone (845) 353-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
8,595 services
Medicare patients, 2024
245
Average age 72
Drug cost, 2024
$2.0M
1,652 prescriptions
Company payments, 2025
$572
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Resnick was code 95004 (test - miscellaneous), 771 times for 38 patients. In total David Resnick billed 8,595 services in 50 codes, and Medicare paid $254K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 771 | 38 | $2.92 | $2,250 |
| 95117 Treatment - Miscellaneous | Office | 217 | 21 | $9.45 | $2,050 |
| 99214 Office E&M - Established | Office | 186 | 108 | $99.34 | $18K |
| 96372 Injection Administration | Office | 186 | 14 | $10.78 | $2,005 |
| 99213 Office E&M - Established | Office | 98 | 70 | $66.08 | $6,476 |
| 36415 Venipuncture Blood Collection | Office | 47 | 34 | $8.56 | $402 |
| 99203 Office E&M - New | Office | 44 | 44 | $79.21 | $3,485 |
| 99204 Office E&M - New | Office | 38 | 38 | $135.77 | $5,159 |
| 80053 Clinical Chemistry | Office | 16 | 11 | $10.35 | $166 |
| 85025 Blood Count | Office | 15 | 11 | $7.61 | $114 |
| 94010 Pulmonary Function Testing | Office | 14 | 14 | $20.11 | $282 |
By year: 2022 $431K for 15,327 services; 2023 $391K for 13,678 services; 2024 $254K for 8,595 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 47 | 34 | $8.56 | $402 |
| 80053 Clinical Chemistry | 16 | 11 | $10.35 | $166 |
| 85025 Blood Count | 15 | 11 | $7.61 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug David Resnick prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 176 prescriptions and refills. In total David Resnick wrote 1,652 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 176 | 319 | 57 | $4,867 |
| Ipratropium Bromide Generic | 152 | 186 | 52 | $5,713 |
| Fluticasone Propionate Generic | 129 | 179 | 45 | $1,938 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 110 | 146 | 22 | $92K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 105 | 147 | 49 | $3,682 |
| Montelukast Sodium Generic | 83 | 191 | 24 | $569 |
| Breo Ellipta Fluticasone/Vilanterol | 81 | 105 | 18 | $40K |
| Prednisone Generic | 63 | 63 | 43 | $119 |
| Advair Hfa Fluticasone Propion/Salmeterol | 61 | 72 | 14 | $25K |
| Omeprazole Generic | 53 | 99 | 15 | $587 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 47 | 67 | 20 | $5,045 |
| Arnuity Ellipta Fluticasone Furoate | 44 | 62 | 15 | $16K |
| Triamcinolone Acetonide Generic | 43 | 56 | 29 | $377 |
| Hydroxyzine Hcl Generic | 41 | 69 | Under 11 | $1,465 |
| Gabapentin Generic | 39 | 61 | Under 11 | $412 |
Brand drugs: 564 claims; generic drugs: 1,088 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Resnick $572 ($572 in general payments such as food, travel and fees) from 8 companies. The largest payer was GlaxoSmithKline, LLC. with $140.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 14 | $140 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $120 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $104 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $94.97 |
| ADMA BioManufacturing LLC | 4 | $37.92 |
| Amgen Inc. AMGN | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $22.54 |
| BioCryst US Sales Co., LLC | 1 | $18.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.